BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 6372701)

  • 21. Improvement of the efficacy and safety of oral methoxsalen photochemotherapy.
    Momtaz-T K; Parrish JA
    Natl Cancer Inst Monogr; 1984 Dec; 66():175-8. PubMed ID: 6531025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
    Berne B; Fischer T; Michaëlsson G; Norén P
    Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid deposition after psoriasis therapy with psoralen and long-wave ultraviolet light.
    Greene I; Cox AJ
    Arch Dermatol; 1979 Oct; 115(10):1200-2. PubMed ID: 507862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of methoxsalen plus near-ultraviolet radiation or mid-ultraviolet radiation on immunologic mechanisms.
    Kripke ML
    Natl Cancer Inst Monogr; 1984 Dec; 66():247-51. PubMed ID: 6531037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo effects of psoralens plus longwave ultraviolet radiation on immunity.
    Morison WL
    Natl Cancer Inst Monogr; 1984 Dec; 66():243-6. PubMed ID: 6335739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of palmoplantar psoriasis with topical methoxsalen plus long-wave ultraviolet light.
    Abel EA; Goldberg LH; Farber EM
    Arch Dermatol; 1980 Nov; 116(11):1257-61. PubMed ID: 7436431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photochemotherapy of psoriasis (PUVA) without specialized equipment.
    Petrozzi JW; Kligman AM
    Arch Dermatol; 1978 Mar; 114(3):387-90. PubMed ID: 629574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the carcinogenic potential of trioxsalen bath PUVA and oral methoxsalen PUVA. A preliminary report.
    Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Berne B
    Arch Dermatol; 1992 Oct; 128(10):1341-4. PubMed ID: 1417020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psoralens and UV-A and UV-B twice weekly for the treatment of psoriasis.
    Diette KM; Momtaz-T K; Stern RS; Arndt KA; Parrish JA
    Arch Dermatol; 1984 Sep; 120(9):1169-73. PubMed ID: 6476854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Photochemotherapy--psoralen + UV-A (PUVA)--increased risk of cancer?].
    Harnes DK; Thune P
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):200-1. PubMed ID: 8430401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutagenicity and carcinogenicity of 8-MOP/UVA in cell cultures.
    Burger PM; Simons JW
    Bull Cancer; 1978; 65(3):281-2. PubMed ID: 719181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lens opacities appearing during therapy with methoxsalen and long-wavelength ultraviolet radiation.
    Lafond G; Roy PE; Grenier R
    Can J Ophthalmol; 1984 Jun; 19(4):173-5. PubMed ID: 6744101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The risks of photochemotherapy (author's transl)].
    Stüttgen G; Kentsch V; Schalla W; Schneider L
    Z Hautkr; 1981 Nov; 56(21):1379-99. PubMed ID: 6458954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skin photosensitizing and Langerhans' cell depleting activity of topical (bath) PUVA therapy: comparison of trimethylpsoralen and 8-methoxypsoralen.
    Koulu L; Jansén CT
    Acta Derm Venereol; 1983; 63(2):137-41. PubMed ID: 6189328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Psoriasis, skin cancer and PUVA].
    Derm Beruf Umwelt; 1981; 29(2):46-7. PubMed ID: 7238301
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term photochemotherapy for psoriasis: a histopathological and clinical follow-up study with special emphasis on tumour incidence and behavior of pigmented lesions.
    Ros AM; Wennersten G; Lagerholm B
    Acta Derm Venereol; 1983; 63(3):215-21. PubMed ID: 6192634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus and widespread cutaneous carcinoma after PUVA photochemotherapy.
    Weinstock MA; Coulter S; Bates J; Bogaars HA; Larson PL; Burmer GC
    Arch Dermatol; 1995 Jun; 131(6):701-4. PubMed ID: 7778923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic allergic contact dermatitis to 8-methoxypsoralen (8-MOP).
    Ravenscroft J; Goulden V; Wilkinson M
    J Am Acad Dermatol; 2001 Dec; 45(6 Suppl):S218-9. PubMed ID: 11712064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy.
    Shephard SE; Panizzon RG
    Dermatology; 1999; 199(2):106-12. PubMed ID: 10559574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re-PUVA.
    Lassus A
    Photodermatol; 1984 Dec; 1(6):263-4. PubMed ID: 6533618
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.